Citadel Advisors
MIRM icon

Citadel Advisors’s Mirum Pharmaceuticals MIRM Stock Holding History

Citadel Advisors’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.07M Sell
9,100
-2,400
-21% -$241K ﹤0.01% 8042
2026
Q1 		$1.06M Sell
11,500
-1,200
-9% -$113K ﹤0.01% 7523
2025
Q4 		$1M Sell
12,700
-300
-2% -$21.5K ﹤0.01% 7382
2025
Q3 		$953K Buy
13,000
+7,100
+120% +$451K ﹤0.01% 7635
2025
Q2 		$300K Sell
5,900
-8,900
-60% -$396K ﹤0.01% 9827
2025
Q1 		$667K Buy
14,800
+12,200
+469% +$575K ﹤0.01% 7834
2024
Q4 		$108K Sell
2,600
-41,500
-94% -$1.73M ﹤0.01% 11371
2024
Q3 		$1.72M Buy
44,100
+19,400
+79% +$774K ﹤0.01% 5819
2024
Q2 		$844K Buy
24,700
+3,100
+14% +$81.3K ﹤0.01% 6939
2024
Q1 		$543K Buy
21,600
+11,100
+106% +$305K ﹤0.01% 8202
2023
Q4 		$310K Buy
10,500
+3,300
+46% +$99.9K ﹤0.01% 9095
2023
Q3 		$228K Sell
7,200
-7,500
-51% -$205K ﹤0.01% 9667
2023
Q2 		$380K Sell
14,700
-5,400
-27% -$144K ﹤0.01% 8520
2023
Q1 		$483K Sell
20,100
-1,500
-7% -$34.2K ﹤0.01% 8393
2022
Q4 		$421K Buy
21,600
+4,000
+23% +$79.1K ﹤0.01% 8597
2022
Q3 		$370K Buy
+17,600
New +$424K ﹤0.01% 9116
2022
Q2 		– Sell
-24,900
Closed -$548K – 13632
2022
Q1 		$548K Sell
24,900
-8,900
-26% -$182K ﹤0.01% 9164
2021
Q4 		$539K Buy
33,800
+4,200
+14% +$65.3K ﹤0.01% 9511
2021
Q3 		$590K Buy
+29,600
New +$481K ﹤0.01% 9465

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors's MIRM Position: Q2 2026 in Review

Citadel Advisors sold out of Mirum Pharmaceuticals (MIRM) in Q2 2026, closing a stake of 1,052,048 shares — an estimated $106M sold.

Citadel Advisors first reported a position in MIRM in Q2 2020 and held it in 22 quarters. The position peaked at $97.2M in Q1 2026. 328 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Citadel Advisors reported no remaining Mirum Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Citadel Advisors sold 1,052,048 Mirum Pharmaceuticals shares in Q2 2026, an estimated $106M.
  • Citadel Advisors first reported a position in Mirum Pharmaceuticals in Q2 2020 and held it in 22 quarters.
  • Citadel Advisors's Mirum Pharmaceuticals position peaked at $97.2M in Q1 2026.
  • 328 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.